Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ariad Pharmaceuticals
Ariad Pharmaceuticals
3 Promising Biotechs for 2014: Ariad, Bristol-Myers, Sanomedics
Wall St Cheat Sheet
Fri, 02/14/14 - 10:36 am
Ariad Pharmaceuticals
Bristol-Myers Squibb
Sanomedics
3 Ways Ariad Pharmaceuticals Can Salvage Iclusig
Motley Fool
Wed, 02/12/14 - 09:19 am
Ariad Pharmaceuticals
Iclusig
acute lymphoblastic leukemia
Why Ariad Pharmaceuticals, Inc. Shares Vaulted Higher
Motley Fool
Sat, 02/8/14 - 10:17 am
Ariad Pharmaceuticals
Ariad Pharma's Executive Stock Giveaway Kills Takeover Hopes
TheStreet.com
Wed, 02/5/14 - 09:38 am
M&A
Ariad Pharmaceuticals
Can Biotech Dominate for a 4th Year in a Row?
Motley Fool
Mon, 02/3/14 - 09:35 am
biotech
IPOs
Amgen
Ariad Pharmaceuticals
Regeneron
Ariad Pharma Short Seller Explains Why Takeover Rumor is Bunk
TheStreet.com
Mon, 01/27/14 - 12:20 pm
Ariad Pharmaceuticals
M&A
AP26113
Eli Lilly
Iclusig
This Week in Biotech: Clinical Success, Plus Wheeling and Dealing
Motley Fool
Sun, 01/26/14 - 10:46 am
BioDelivery Sciences
Endo Health Solutions
Karyopharm Therapeutics
Repligen
Biomarin
Ariad Pharmaceuticals
Eli Lilly
GSK
Shire
Ariad shares jump nearly 30% on rumors of Big Pharma takeover
Marketwatch
Fri, 01/24/14 - 06:01 pm
Ariad Pharmaceuticals
M&A
Eli Lilly
GSK
Shire
With Iclusig back to market, would Eli Lilly bid for Ariad? Would anyone?
Fierce Pharma
Fri, 01/24/14 - 09:12 am
Iclusig
M&A
Ariad Pharmaceuticals
Eli Lilly
Ariad Joins Rumor Mill: Hope May Trump Reality
Wall St 24/7
Thu, 01/23/14 - 11:06 am
Ariad Pharmaceuticals
Eli Lilly
M&A
The Best- And Worst-Performing Biotech Stocks Of 2013
Forbes
Thu, 01/2/14 - 10:45 am
biotech
Puma Biotechnology
Acadia
Isis Pharmaceuticals
Infinity Pharmaceuticals
Amarin
Ariad Pharmaceuticals
Aveo Oncology
4 Biggest Biotech Disasters Of 2013
Forbes
Wed, 01/1/14 - 11:41 am
Amarin
Vascepa
Ariad Pharmaceuticals
Iclusig
Celsion
ThermoDox
IPI-145
Infinity Pharmaceuticals
Ariad Pharmaceuticals Catches Fire
TheStreet.com
Mon, 12/23/13 - 10:03 am
Ariad Pharmaceuticals
Iclusig
FDA
This Week in Biotech
Motley Fool
Sun, 12/22/13 - 12:28 pm
GSK
Theravance
Ariad Pharmaceuticals
Gilead Sciences
AbbVie
Cubist Pharmaceuticals
Jazz Pharmaceuticals
Gentium
Why Ariad Pharmaceuticals is Soaring
The Street
Sat, 12/21/13 - 11:27 am
Ariad Pharmaceuticals
Ariad says FDA OKs marketing of Iclusig after adding new safety warnings
Yahoo/AP
Fri, 12/20/13 - 11:35 am
Ariad Pharmaceuticals
FDA
Iclusig
warnings
3 Drugmakers to Watch in the New Year
Motley Fool
Wed, 12/11/13 - 11:10 am
pimavanserin
Acadia
Zerenex
Keryx
Iclusig
Ariad Pharmaceuticals
3 Biggest FDA Decisions of 2013
Motley Fool
Wed, 12/4/13 - 08:18 am
FDA
Sarepta Therapeutics
drisapersen
Iclusig
Ariad Pharmaceuticals
Vascepa
Amarin
Opportunities in Lung Cancer Therapies
Motley Fool
Sun, 11/24/13 - 12:30 pm
lung cancer
non-small cell lung cancer
Avastin
Genentech
Roche
Tarceva
AstraZeneca
Iressa
Alimta
selumetinib
Array Biopharma
CO-1686
Clovis Oncology
AP26113
Ariad Pharmaceuticals
Ariad jumps as company says EU regulators may be willing to keep its cancer drug on the market
Yahoo/AP
Fri, 11/22/13 - 11:42 am
Europe
Iclusig
Ariad Pharmaceuticals
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »